![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » BIOPHAN RESTRUCTURES BOARD IN CONNECTION WITH APPLICATION FOR LISTING ON NATIONAL EXCHANGE
BIOPHAN RESTRUCTURES BOARD IN CONNECTION WITH APPLICATION FOR LISTING ON NATIONAL EXCHANGE
June 15, 2006
Biophan Technologies, Inc., a developer of next-generation medical technology, today announced that it is reducing the size of its board of directors from 7 to 5 members in order to have a majority of independent directors to satisfy one of the qualifications for listing on a major national stock exchange. Genetic Engineering News (http://www.genengnews.com/news/bnitem.aspx?name=2554236)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct